Dr Daniel Drucker in his lab at the Lunenfeld-Tanenbaum Research Institute (IMAGE)
Caption
GLP-1 pioneering researcher Dr. Daniel Drucker, has made it his life's work to understand how these popular diabetes and weight-loss drugs work in the body. His team's latest study begins to unpack how these drugs reduce systemic inflammation which is throught to be the reason behind their beneficial effects on health beyond weight loss.
Credit
please credit Colin Dewar
Usage Restrictions
none with
License
Original content